The critical role of mesenchymal stromal/stem cell therapy in COVID ‐19 patients: An updated review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The critical role of mesenchymal stromal/stem cell therapy in COVID ‐19 patients: An updated review

Published:2021-09-20 Issue:8 Volume:39 Page:945-954
ISSN:0263-6484
Container-title:Cell Biochemistry and Function
language:en
Short-container-title:Cell Biochem Funct

Author:

Ebrahimi Mohsen¹,Rad Mohammad Taha Saadati²,Zebardast Arghavan³,Ayyasi Mitra⁴,Goodarzi Golnaz⁵⁶,Tehrani Sadra Samavarchi⁵⁶^ORCID

Affiliation:

1. Neonatal and Child Health Research Center Golestan University of Medical Sciences Gorgan Iran

2. Psychiatric and Behavioral Sciences Research Center, Addiction Research Institute Mazandaran University of Medical Sciences Sari Iran

3. Department of Virology, School of Public Health Tehran University of Medical Sciences Tehran Iran

4. Critical Care Nursing Islamic Azad University, Sari Branch Sari Iran

5. Department of Clinical Biochemistry, School of Medicine Tehran University of Medical Sciences Tehran Iran

6. Scientific Research Center Tehran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,General Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbf.3670

Reference137 articles.

1. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

2. Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19

3. Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19

4. Expression and co-expression analyses of TMPRSS2, a key element in COVID-19

5. The cytokine storm and COVID‐19

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of different types of liposomal nano structures for microRNA transfection to human mesenchymal stem cell line S1939;Nucleosides, Nucleotides & Nucleic Acids;2022-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3